Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials

Ultra-low Dose Oral Ketamine for Treatment of Chronic Non-cancer Pain in the Primary Care Setting

To see complete record on, please visit this link

Id: NCT02303847

Organisation Name: University of Washington

Overal Status: Unknown status

Start Date: November 2014

Last Update: May 27, 2015

Lead Sponsor: University of Washington

Brief Summary: This project is a pilot study to evaluate the analgesic and opioid-sparing effects of ketamine in an ultra-low dose oral formulation as a novel intervention for treatment of chronic non-cancer pain in opioid-tolerant patients in the primary care outpatient setting.

  • Chronic Pain

Total execution time in seconds: 0.27045106887817